News

UK ranked poorly on access to cancer drugs

10-May-07

Research from Sweden has ranked the UK as one of the lowest in the world for its ‘slow and low’ uptake of modern cancer therapies.

The research was carried out by the Karolinska Institute and Stocholm School of Economics and published in the Annals of Oncology.

Worldwide, the US, Austria, France and Switzerland were the found to be the best.

France had the highest five-year survival rate in Europe - 71 per cent in women and 53 per cent in men. These figures were found to be only 53 per cent and 43 per cent in the UK, for women and men respectively.

Lead researcher Dr Begt Jonsson said: 'It is our hope that this report will inspire policy-makers to take action to address these imbalances so that access to new innovative cancer drugs does not become dependent on the patient's country of residence.'

What do you think? Comment below or email us healthcare.republic@haymarket.com

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Registrar

RCGP Curriculum - 15.8 Respiratory Problems

This section of our curriculum guide refers to statement 15.8, Respiratory Problems, produced by the... Read more

RCGP Curriculum - 15.10 Skin Problems

This section of our curriculum guide refers to statement 15.10, Skin Problems, produced by the Royal... Read more

RCGP Curriculum - 13 Care of People with Mental Health Problems

This section of our curriculum guide refers to statement 13, Care of People with Mental Health Probl... Read more

Show all articles

 

Latest Clinical Articles

Chronic constipation

Contributed by Dr Naila Arebi, consultant gastroenterologist, St Mark's Hospital, Harrow, and The Lo... Read more

Sexually transmitted infections

Contributed by Dr Alan McOwan, lead clinician, Victoria Clinic for HIV and Sexual Health, London. Read more

Pemphigus

Contributed by Dr Sacha Goolamali, dermatology specialist registrar and Dr Rachael Morris-Jones, con... Read more

Show all clinical articles

MIMS Product News

New drug - NuvaRing

A non-daily, low oestrogen contraceptive utilising a vaginal delivery system. Read more

New drug - Siklos

Nordic Pharma has launched Siklos (hydroxycarbamide) for the prevention of recurrent painful vaso-oc... Read more

New drug - Bridion

Schering-Plough has launched Bridion (sugammadex) for the reversal of neuromuscular blockade induced... Read more

Jobs

 

Job of the Week